Hendra Carla C
Known title: DirectorCIK: 0001345575
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Edgewell Personal Care (EPC) Highlighted in Recent Analyst Coverage. Recent Yahoo coverage noted that Edgewell Personal Care is the subject of a refocus story that keeps an undervalued view in play. The company was also listed as a safe‑and‑steady stock facing limited headwinds. Additionally, the agenda for the upcoming Palm Beach Corporate Governance Forum includes discussions on activism and other topics that could be relevant to EPC.
Transaction History
| CAL | ▼ Sell | Open Market | 5,349 | $177K | 7/15/2024 | View on chart |
| CAL | ▲ Buy | Option Exercise | 5,349 | — | 5/26/2024 | View on chart |
| EPC | ▲ Buy | Option Exercise | 573 | $0 | 4/3/2024 | View on chart |
| EPC | ▲ Buy | Option Exercise | 3,318 | $0 | 1/31/2024 | View on chart |
| EPC | ▲ Buy | Option Exercise | 651 | $0 | 1/3/2024 | View on chart |
| CAL | ▼ Sell | Open Market | 2,493 | $51K | 6/8/2023 | View on chart |
| CAL | ▼ Sell | Open Market | 2,536 | $50K | 6/7/2023 | View on chart |
| CAL | ▲ Buy | Option Exercise | 5,029 | — | 6/2/2023 | View on chart |
| EPC | ▲ Buy | Option Exercise | 3,375 | $0 | 2/2/2023 | View on chart |
| CAL | ▼ Sell | Open Market | 13,208 | $372K | 6/3/2022 | View on chart |
| CAL | ▲ Buy | Option Exercise | 13,208 | — | 5/26/2022 | View on chart |
| CAL | ▼ Sell | Open Market | 3,261 | $68K | 3/17/2022 | View on chart |
| EPC | ▼ Sell | Open Market | 3,799 | $133K | 3/1/2022 | View on chart |
| EPC | ▲ Buy | Option Exercise | 3,799 | $0 | 2/3/2022 | View on chart |
| EPC | ▼ Sell | Open Market | 7,100 | $312K | 11/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Caleres Q2 Performance Reviewed in Consumer Discretionary Sector
Recent market reviews have examined Caleres' second-quarter results alongside other footwear and consumer discretionary stocks. The company is currently trading near its 52-week low, with technical indicators showing a touch of the 200-day moving average and support confirmation. These factors provide context for its position within the broader retail sector.
Caleres Q2 Performance Reviewed in Consumer Discretionary Sector. Recent market reviews have examined Caleres' second-quarter results alongside other footwear and consumer discretionary stocks. The company is currently trading near its 52-week low, with technical indicators showing a touch of the 200-day moving average and support confirmation. These factors provide context for its position within the broader retail sector.